baber/WOPTO huggingface dataset:
Patent NZ-250637-A (NZ)
Title: Pump tank with submersible pump lowered on guides to outlet pipe having a connection support part in the recess of a sloping plane
Inventor: PETTERSSON NILS-ERIK
IPC: F04D29/60
Filed: 1994-01-06
Abstract: The sewage pumping station comprises a tank (2) with inlet (4), and bottom formed by steeply sloping sides (6, 7) for minimising the build-up and eventual clogging of pumping equipment. The submersible pump (8) has an inlet (9), flanged outlet (11), and is raised and lowered for maintenance on guides (15). When lowered, the pump outlet flange (11) makes an un-bolted connection with the flange (14) on the first bend (13) of the discharge pipe. The bend (13), support (12), and part of the discharge riser and guide assembly (15), are accommodated in a slot recess in the sloping bottom wall (7).
Patent NZ-259901-A (NZ)
Title: Anti-lfa monoclonal antibody preparations and their use in preventing organ rejection
Inventor: ALBERICI GILLES
IPC: A61K39/395
Filed: 1994-01-21
Abstract: Mean survival times of a functional transplant of solid organs in a patient are increased by administering to the patient an initial dosing of a therapeutically effective amounts of a monoclonal antibody directed against the human LFA-1 molecule in the two hours after grafting and then administering daily dosing during a period of approximately nine days.
Patent NZ-273285-A (NZ)
Title: Insulin derivatives and compositions thereof
Inventor: HAVELUND SVEND
IPC: C12R1/19
Filed: 1994-09-16
Abstract: The present invention relates to protracted human insulin derivatives in which the A21 and the B3 amino acid residues are, independently, any amino acid residue which can be coded for by the genetic code except Lys, Arg and Cys; Phe may be deleted; the B30 amino acid residue is a) a non-codable, lipophilic amino acid having from 10 to 24 carbon atoms, in which case an acyl group of a carboxylic acid with up to 5 carbon atoms is bound to the ELEMENT -amino group of Lys<829>; or b) the B30 amino acid residue is deleted or is any amino acid residue which can be coded-for by the genetic code except Lys, Arg and Cys, in any of which cases the ELEMENT -amino group of Lys has a lipophilic substituent; and any Zn<2+> complexes thereof with the proviso that when B30 is Thr or Ala and A21 and B3 are both Asn, and Phe is present, then the insulin derivative is always present as a Zn<2+> complex.
Patent NZ-292471-A (NZ)
Title: Polymer beads incorporating a solid phase dispersing agent in the polymer and method of preparation
Inventor: BALLARD MATHEW JOHN
IPC: C08F2/44
Filed: 1995-09-08
Abstract: The present invention relates to a process for producing polymer beads incorporating solid particles and to the novel polymer beads per se. The invention provides a process for producing polymer beads incorporating solid particulate material, which process comprises producing a dispersion having a dispersed phase including one or more monomers also including solid particulate material, and causing said one or more monomers to undergo a polymerisation reaction to form said polymer beads, wherein said dispersion further includes a solid phase dispersing agent for dispersing solid particles of material in the dispersed phase and wherein said solid phase dispersing agent reacts with at least one monomer to thereby become chemically incorporated in said polymer. The polymer beads comprise a polymer matrix having solid particulate material dispersed substantially uniformly therein and wherein the polymer matrix incorporates a solid phase dispersing agent chemically reacted into the polymeric matrix.
Patent NZ-311982-A (NZ)
Title: Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies
Inventor: GOODWIN RAYMOND GEORGE
IPC: A61K38/00
Filed: 1996-06-25
Abstract: A novel cytokine designated TRAIL induces apoptosis of certain target cells, including cancer cells and virally infected cells. Isolated DNA sequences encoding TRAIL are disclosed, along with expression vectors and transformed host cells useful in producing TRAIL polypeptides. Antibodies that specifically bind TRAIL are provided as well.
Patent NZ-318549-A (NZ)
Title: A method of socketing a pipe
Inventor: JOHANSSON MATS
IPC: F16L55/165
Filed: 1996-09-20
Abstract: A method of socketing a pipe of oriented plastic having an annular groove inside the socket. An end portion (15) of the pipe is pushed onto a cylindrical mandrel element (11) and the region (l1) of the end portion at the opening thereof where the groove is to be located is heated to a temperature above the glass transition temperature of amorphous plastic and the crystalline melting point of crystalline plastic, respectively. The rest of the end portion is maintained at a temperature below the glass transition temperature or the crystalline melting point, respectively. The end portion (15) when said region is at a temperature above the glass transition temperature or the crystalline melting point, respectively, is pushed onto a second mandrel element (13) axially aligned with said first mandrel element the bottom portion of the socket being formed by said second mandrel element (13). The rest of the end portion is expanded to form the bottom portion of the socket. The end portion of the pipe is cooled and is then withdrawn from the mandrel elements.
Patent NZ-331022-A (NZ)
Title: Retrofit electroluminescent (EL) lighting system for gaming machine, uses machine's lamp power signals to control EL lights
Inventor: BEVINGTON MARK
IPC: H05B44/00
Filed: 1997-01-23
Abstract: A retrofit electroluminescent (EL) lighting system for use with a gaming machine 104 produces lighting effects in response to lamp power signals from the gaming machine that would otherwise be used to power ordinary incandescent lamps on the gaming machine.  The EL system 108 has several cells.  Sequencing circuitry 106 provides an EL lamp driving signal to independently control each of the EL lamp cells so that the EL lamp cells illuminate in sequence.  A microcontroller controls the frequency, amplitude, and duty cycle to the EL lamps to vary the colour and intensity of the EL lamps.  The microcontroller also selects which lamps to illuminate, so that animated displays are produced.  The sequencing circuitry 106 has signal level detection circuitry that monitors the level of the EL lamp driving signal and drives the EL lamps in response to the detected signal level.
Patent NZ-332160-A (NZ)
Title: Process for purifying sterically hindered 4-amino piperidines
Inventor: JULIUS MANFRED
IPC: C07D221/20
Filed: 1997-05-30
Abstract: PCT No. PCT/EP97/02822 Sec. 371 Date Nov. 12, 1998 Sec. 102(e) Date Nov. 12, 1998 PCT Filed May 30, 1997 PCT Pub. No. WO97/46529 PCT Pub. Date Dec. 11, 1997A process for purifying crude piperidines of the formula I where R1 to R4 are C1-C6-alkyl, or R1 and R2 and/or R3 and R4 together are a CH2-chain of 2 to 5 carbons, which comprises, in a first step, removing high-boiling substances and, if present, water from the crude piperidines by distillation; in a second step, adding from 0.01 to 5% by weight, based on the product of the first step, as a reducing agent; and, in a third step, isolating the piperidines by distillation.
Patent NZ-332931-A (NZ)
Title: Process for the selective production of acetic acid from a gaseous feed and oxygen
Inventor: BORCHERT HOLGER
IPC: C07C11/04
Filed: 1997-05-16
Abstract: The process for the selective preparation of acetic acid from a gaseous feed and oxygen at elevated temperatures comprises bringing the gaseous feed into contact with a catalyst of formula I MoaPdbRecXdYe comprising Mo, Pd, Re, X and Y in gram atom ratios a:b:c:d:e in combination with oxygen wherein: X is Cr, Mn, Nb, B, Ta, Ti, V and/or W; Y is Bi, Ce, Co, Cu, Te, Fe, Li, K, Na, Rb, Be, Mg, Ca, Sr, Ba, Ni, P, Pb, Sb, Si, Sn, Ti and/or U and a is 1, b>0, c>0, d is 0.05-2 and e is 0-3. The gaseous feed comprises ethane, ethylene or mixtures thereof.
Patent NZ-501888-A (NZ)
Title: Paclitaxel 2'-methyl-pyridinium mesylate, phosphate or bicarbonate salts
Inventor: DIGENIS GEORGE
IPC: C07F9/02
Filed: 1997-06-20
Abstract: The 2'-onium salts of paclitaxel - "paclitaxel-2'-methyl-pyridinium mesylate, paclitaxel-2'-methyl-pyridinium phosphate and paclitaxel-2'-methyl-pyridinium bicarbonate" are disclosed. A dosage form thereof is useful for treating a patient suffering from a paclitaxel responsive disease condition.
Patent NZ-504570-A (NZ)
Title: Site-specific preparation of hGRF-PEG with PEG units covalently bound to Lys12, Lys21 or amino terminal
Inventor: VERONESE FRANCESCO MARIA
IPC: A61K47/48
Filed: 1998-12-01
Abstract: A method is described for the site-specific preparation of hGRF-PEG conjugates containing one or more PEG units (per hGRF) covalently bound to Lys12 and/or Lys21 and/or Ná, comprising carrying out a pegylation reaction between the hGRF peptide and the activated PEG in solution at a pH between 7 and 9 and thereafter isolating and purifying the desired hGRF-PEG from the reaction mixture by chromatography. The conjugates prepared by this method, as well as their use in the treatment and/or diagnosis of growth hormone deficiency, are also described.
Patent NZ-507585-A (NZ)
Title: Cubane analogs with activity at the metabotropic glutamate receptors
Inventor: CURRY KENNETH
IPC: A61P25/28
Filed: 1999-04-19
Abstract: Therapeutically active cubane compounds, a method of preparing the same, and to pharmaceutical compositions comprising the compounds are disclosed. These compounds are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
Patent NZ-507625-A (NZ)
Title: Human BMP-7 promoter and method for exploring bone- related substance by using the same
Inventor: KAWAI SHINJI
IPC: A61K48/00
Filed: 1999-04-22
Abstract: A DNA molecule with nucleotide sequence SEQ ID NO.1 that encodes a human bone morphogenetic protein-7 promoter region, and a method for its preparation. Also, in a method of exploring for a bone-related substance, the DNA is integrated into a recombinant expression vector and used to measure the reporter activity.
Patent NZ-507808-A (NZ)
Title: Method and apparatus for ordering goods, services and content over an internetwork
Inventor: DOMINGUEZ ROBERTO
IPC: G06Q20/00
Filed: 1999-04-22
Abstract: A method for ordering a product over an internetwork of computer systems, wherein the product is ordered from a consumer computer (42) connected to the internetwork and billed by a billing server (34) connected to the internetwork comprises: (a) establishing a connection between the consumer computer and the billing server via the internetwork of computer systems; (b) transferring an order for a product from the consumer computer to the billing server via the internetwork; (c) transferring a transaction identification from the billing server to the consumer computer, wherein the transaction identification identifies the product ordered; (d) terminating the connection between the consumer computer and the billing server via the internetwork after the transaction identifier has been received by the consumer computer via the internetwork; (e) establishing a direct connection between the consumer computer and the billing server such as a telephone link administered by a telephone service provider and (f) transferring the transaction identification from the consumer computer back to the billing via the direct connection to identify the product ordered.
Patent NZ-510274-A (NZ)
Title: De novo nucleotide sequences in hybrid plants generated from a cross between Tripascum dactyloides L and Zea diploperennis Iltis and their transmission into maize
Inventor: EUBANKS MARY WILKES
IPC: A01H5/10
Filed: 1999-08-05
Abstract: A method for transferring novel genetic materials into maize. The method for deriving these new genes is via wide cross hybrid plants produced by crossing two wild relatives of maize, Eastern gamagrass (Tripsacum) and perennial teosinte (Zea diploperennis). This invention thus relates to the novel genetic materials in hybrid seed, the hybrid plant produced by the seed and/or tissue culture, variants, mutants, modifications, and cellular and molecular components of Tripsacum-perennial teosinte hybrids, and the hybrid seed, the hybrid plant produced by the seed and/or tissue culture, variants, mutants, modifications, and cellular and molecular components of (maize X Tripsacum-perennial teosinte) and/or Tripsacum-perennial teosinte X maize). In particular this invention is directed to the ability to transfer de novo nucleotide sequences and novel alleles from Tripsacum to maize for use in genetic analyses and selection of novel genotypes with enhanced agronomic traits such as insect and disease resistance, drought tolerance, cold tolerance, tolerance to water-logging, apomixis, totipotency, perennialism, as well as adaptation to adverse soil conditions and a carbondioxide enriched atmosphere via (maize X Tripsacum-perennial teosinte) hybrids in corn improvement programs.
Patent NZ-510591-A (NZ)
Title: Flexible membrane, typically for footwear, with at least ten layers of microlayers, alternating between fluid barriers and elastomeric material
Inventor: BONK HENRY W
IPC: A43B13/20
Filed: 1999-09-10
Abstract: Described is a membrane (28) comprising  a  microlayer polymeric  composite having at least about  10  microlayers. The  microlayers  are  each individually  up  to  about  100 microns  thick  and  alternate between at  least  one  fluid barrier material and at least one elastomeric material.  The membrane  (28) can be formed into a pressurized  bladder  or cushioning device for many applications, including  footwear and hydropneumatic accumulators.
Patent NZ-513850-A (NZ)
Title: Method and apparatus for manufacturing innerspring assemblies
Inventor: WHITWORTH IAN JAMES
IPC: A47C27/06
Filed: 2000-03-13
Abstract: A method for the manufacture of an innerspring assembly, suitable for a mattress, cushion or the like, comprises the steps of a) positioning a first string (6) of pocketed coil springs in juxtaposition with a plurality of adhesive applicators (12) disposed in mutually fixed relation on an axis parallel to a longitudinal axis of said first string (6), b) applying adhesive from said adhesive applicators (12) to said first string (6) of pocketed coil springs, and c) bringing said first string (6) into adhesive contact with a second string (6a) of pocketed coil springs. Apparatus for carrying out the method is also disclosed, as are innerspring assemblies produced by the method.
Patent NZ-519361-A (NZ)
Title: Electronic spinning reel game with fixed position bonus or wild symbol
Inventor: BENNETT NICHOLAS LUKE
IPC: G07F17/34
Filed: 2001-03-23
Abstract: A video gaming machine plays and displays a spinning reel game, and if a random event is displayed the machine awards a prize. When a special symbol (a bonus symbol) 42 appears on the display, the special symbol is held in a superimposed representation in that position for at least one further game while at least the reel carrying the or each special symbol is re-spun for the further game.
Patent NZ-523303-A (NZ)
Title: Use of secretin-receptor ligands in the treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)
Inventor: DAVIS RICHARD JON
IPC: A61K31/24
Filed: 2001-07-04
Abstract: The use of an agent which triggers anion efflux in respiratory tissue via the activation of a secretin receptor for the manufacture of a medicament for the treatment of cystic fibrosis (CF) or chronic obstructive pulmonary disease (COPD) in a patient.
Patent NZ-523512-A (NZ)
Title: Washing and recycling unit and method for on-site washing of heavy machinery
Inventor: MATHIEU CHRISTIAN
IPC: B60S3/04
Filed: 2001-07-05
Abstract: A washing and recycling unit for on-site washing of heavy machinery is disclosed. The unit has a supporting frame onto which is mounted a washing liquid storage tank. A washing hose arrangement connected to the tank injects washing liquid over the heavy machinery. A drainage receptacle positioned under the heavy machinery collects used liquid mixture falling from the heavy machinery. The used liquid mixture is sucked up with a suction hose connected to a cyclone which separates rough solids from liquids. A pump and filtering arrangement recycles liquid from a settling tank under the cyclone by pumping it out, filtering it and transferring it into the washing liquid storage tank. A hoisting system mounted onto the supporting frame is used to movably support an operator directing the washing liquid around the heavy machinery.
Patent NZ-527670-A (NZ)
Title: Intelligent wireless messaging system
Inventor: LOVEYS MARK CAMPITT
IPC: H04Q3/66
Filed: 2002-06-14
Abstract: A system for handling an order which is received from any 'text messaging" or other wireless data transmission protocol capable wireless communication device comprises: a means for receiving an order message from the wireless device; a means for extracting an indication of the identity of the wireless device from the order message a means for obtaining information associated with the indicated identity where the information comprises information on a wireless device user associated with the wireless device identity and a nominated method of payment for the order and a means for sending an order confirmation message using the identity to the wireless device.
Patent NZ-527738-A (NZ)
Title: Fused cheese processing apparatus
Inventor: MISSON GREGORY CHARLES
IPC: A01J25/00
Filed: 2003-08-21
Abstract: An apparatus for the substantially continuous processing of forming cheese. In one processing method the apparatus can be utilised to process cheese milk (coagulum) through to particulate cheese. The apparatus comprises a de-watering or cheddaring tower (5) including a column (18) having an inlet (4) in which a pillar of cheese can fuse. Drainage manifolds (8) allow the why to discharge. The column joins with a detritising cutting means (10) provided at the lower end of the column. The cutting means removes cheese from the lower end of the pillar as it makes contact therewith. Simultaneously and consequently the cutting means forms a quantity of particulate cheese which is deposited into conveyor means (12) for transport downstream as indicated by arrow 14. Secondary detritising means (20) may be included and if so preferably both detritising means are mounted in a hopper (11) with the conveyor at the lower end thereof. The inlet may be fed from a hopper (1) incorporated into the inlet to enable particulate cheese to be charged into the column. In this manner the apparatus can be utilised in a second processing method to re-process fused or particulate cheese through a further or secondary fusion step back to particulate cheese. Typically this method or processing step is utilised as part of downstream processing such as salting. A plant may involve more than one pf the apparatus joined in line to carry out the aforesaid processing methods or steps.
Patent NZ-528394-A (NZ)
Title: Pharmaceutical combinations for the treatment of cancer comprising dioxolane analogues and nuceloside analogues and/or chemotherapeutic agents
Inventor: GILES FRANCIS J
IPC: A61K31/704
Filed: 2002-03-25
Abstract: A pharmaceutical composition for the treatment of cancer comprises a compound of formula (I), wherein B is cytosine or 5-fluorocytosine and R is H, monophosphate, diphosphate, triphosphate, carbonyl substituted with a C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, or a substituent of formula (2), wherein each Rc is independently selected from the group comprising H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl and an hydroxy protecting group; and gemcitabine, and the ratio of the compound of formula (I) to gemcitabine is 1:250 to 250:1.
Patent NZ-531786-A (NZ)
Title: Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
Inventor: WALKER DANIEL PATRICK
IPC: A61P25/18
Filed: 2002-10-01
Abstract: Disclosed are azabicyclic-substituted fused-heteroaryl compounds of formula 1 wherein azabicyclo is one of formula I-VI, W, X and R1 are as defined in the specification. Compounds of the type disclosed are alpha7 nicotinic acetylcholine receptor (alpha7nAChR) agonists and are useful in the treatment of disorders such as cognitive and attention deficit symptoms of Alzheimer's disease, schizophrenia, psychosis, depression, anxiety, post traumatic stress disorder, attention deficit hyperactivity disorder, attention deficit disorder, mood and affective disorders amongst others.
Patent NZ-535133-A (NZ)
Title: Halar membranes
Inventor: MULLETTE DANIEL
IPC: B01D69/06
Filed: 2003-02-12
Abstract: Disclosed is an asymmetric polymeric ultrafiltration or microfiltration membrane including Halar (poly(ethylene chlorotrifluoroethylene)). Preferred solvents, coating agents and pore forming agents are citric acid ethyl ester or glycerol triacetate. The membranes may be in the form of a hollow fibre or flat sheet, and may include other agents to modify the properties of the membrane, such as the hydrophilic/hydrophobic balance.
Patent NZ-535223-A (NZ)
Title: Triggering event processing
Inventor: SPRIGG STEPHEN A
IPC: H04L29/08
Filed: 2003-12-19
Abstract: A method for processing a triggering even associated with information is disclosed. The method comprises a) receiving a triggering event parameter associated with the information; b) receiving extra data capable of being processed; c) monitoring the triggering event parameter; d) when the monitoring of the triggering event parameter indicates that the triggering event has occurred, placing the extra data in a queue; e) determining that a remote connection is available for processing of the extra data; and f) retrieving the extra data from the queue and processing the extra data. In some embodiments, the triggering even parameter is an expiration parameter for permission to use an application and the extra data is a URL for processing the expiration of the application.
Patent NZ-539954-A (NZ)
Title: New tricyclic derivatives as LTD4 antagonists
Inventor: PUIG DURAN CARLOS
Filed: 2003-11-11
Abstract: Disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein: from one to three of A1, A2, A3 and A4 are nitrogen atoms, the others being -CR1- groups; G1 represents a group selected from -CH2-O-, -CH2-CH2-, -CH=CH-, -CH2-S-,   -N(C1-C4alkyl)-CH2; G2 represents a group selected from -O-CH2-, -CH=CH-, -CH2-CH2-; each of R1, R2, R3 and R4 is the same or different and is selected from hydrogen or halogen atoms and hydroxy, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy, C1-C8 alkylthio, amino, mono(C1-C8 alkyl)amino, di(C1-C8 alkyl)amino, nitro, cyano, acyloxy, (C1-C8 alkoxy)carbonyl, hydroxycarbonyl or acylamino groups, the hydrocarbon chains of these groups being optionally substituted by one or more further substituents selected from halogen, hydroxy, oxo, C1-C8 alkoxy, C1-C8 alkylthio, acylamino, phenyl, (C1-C8 alkoxy)carbonyl, amino, mono(C1-C8 alkyl)amino, di(C1-C8 alkyl)amino and hydroxycarbonyl groups; n, m and p are independently 0, 1 or 2; Y represents a C1-C8 alkyl, C3-C7 cycloalkyl, C5-C14 aryl, (C1-C8 alkyl)-(C3-C7 cycloalkyl), (C3-C7 cycloalkyl)-(C1-C8 alkyl), (C5-C14 aryl)-( C1-C8 alkyl), (C1-C8 alkyl)-(C5-C14 aryl), (C1-C8 alkyl)-(C3-C7 cycloalkyl)-(C1-C8 alkyl), (C3-C7 cycloalkyl)-(C1-C8 alkyl)-(C3-C7 cycloalkyl), (C1-C8 alkyl)-(C5-C14 aryl)-(C1-C8 alkyl) and (C5-C14 aryl)-(C1-C8 alkyl)-(C5-C14 aryl) group, each alkyl, cycloalkyl and aryl moiety in said group being unsubstituted or substituted by 1, 2 or 3 substituents selected from halogen, hydroxy and C1-C4 alkoxy substituents; Z represents a tetrazolyl group, a -COOR5 group, a -CONR5R5 group, a -NHSO2R5 group or -CONHSO2R5 group wherein R5 represents hydrogen or a C1-C8 alkyl, C5-C14 aryl, C3-C7 cycloalkyl, 3- to 10- membered heterocyclyl or 5- to 10- membered heteroaryl group which is unsubstituted or substituted by 1, 2 or 3 substituents selected from halogen, hydroxy and C1-C4 alkoxy substituents, each acyl moiety in R1 to R4 being a C2-C8 radical attached to a carbonyl radical. The compounds are LTD4 receptor antagonists useful in the treatment of inflammatory and allergic diseases.